Russell Frank Company’s GSK GSK Stock Holding History

Russell Frank Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-13,158	Closed	-$632K	–	3005
2015 Q3	$632K	Buy	+13,158	New	+$685K	﹤0.01%	2403
2014 Q3	–	Sell	-34,218	Closed	-$2.07M	–	2869
2014 Q2	$2.07M	Sell	34,218 -26,180	-43%	-$1.77M	﹤0.01%	1734
2014 Q1	$4.03M	Buy	60,398 +42,627	+240%	+$2.88M	0.01%	1404
2013 Q4	$1.15M	Sell	17,771 -89,708	-83%	-$5.82M	﹤0.01%	2014
2013 Q3	$6.74M	Sell	107,479 -57,255	-35%	-$3.69M	0.01%	1132
2013 Q2	$10.3M	Buy	+164,734	New	+$10.5M	0.02%	840

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Russell Frank Company's GSK Position: Q4 2015 in Review

Russell Frank Company sold out of GSK (GSK) in Q4 2015, closing a stake of 13,158 shares — an estimated $632K sold.

Russell Frank Company first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $10.3M in Q2 2013. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Russell Frank Company reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
Russell Frank Company sold 13,158 GSK shares in Q4 2015, an estimated $632K.
Russell Frank Company first reported a position in GSK in Q2 2013 and held it in 6 quarters.
Russell Frank Company's GSK position peaked at $10.3M in Q2 2013.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.